Upcoming Webinars

Join SIO for a three-part webinar series on hepatocellular carcinoma (HCC) this fall. Part one will cover advances in treatment with a shift toward combination therapies and sequencing strategies to optimize patient outcomes. Part two will explore the role of immunotherapy in HCC, including combinations with locoregional therapies, mechanisms of resistance, biomarker predictions and other therapeutic targets. Part three will highlight ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

To get the most out of the series, we recommend registering for all three sessions. Soon after a session has been completed, they will be made available on the on-demand webinars page. 

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7 – 8:30 p.m. ET

This webinar is sponsored by:

Faculty

Moderator

Zach Berman, MD

UC San Diego

Faculty Panel

Adam Burgoyne, MD, PhD

UC San Diego

Kirema Garcia-Reyes, MD

Mount Sinai

Christopher Malone, MD

Washington University

Register Now

This webinar series is sponsored by:

Catch up anytime — previous webinars in this series are available on our on-demand page.

View On-Demand Webinars

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization. Part two will focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three addresses the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions. Soon after a session has been completed, they will be made available on the on-demand webinars page. 

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Tuesday, 11 November 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Sirish Kishore, MD 

Stanford University 

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

Bone Club is supported by:

Monday, 17 November 2025 | 6:30 - 7:30 p.m. ET

Explore findings from a landmark multicenter randomized trial comparing embolization strategies for liver-dominant neuroendocrine tumor metastases. This session will examine early clinical outcomes, challenges in conducting multicenter prospective trials, and implications for clinical practice. Attendees will gain insights into trial design, safety monitoring, and how emerging data may shape future research and guideline recommendations in liver-directed therapies.

Faculty

Gavin Yuang, MD

Virginia Mason Franciscan Health

Michael Soulen, MD, FSIR, FCIRSE

University of Pennsylvania

Register Now

This webinar is sponsored by:

Tuesday, 18 November 2025 | 7 - 8:30 p.m. ET

Microwave ablation is advancing rapidly in interventional oncology. This webinar will review the latest techniques, showcase real-world experiences, and discuss how new innovations are enhancing precision, efficiency, and patient outcomes.

Faculty

Kirema Garcia-Reyes, MD

Mount Sinai Health System

Brian T. Welch, MD

Mayo Clinic

Register Now

This webinar is sponsored by:

Postponed: Stay tuned for more details 

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies. 

Faculty

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by: